Patents/Assignees

Nkarta, Inc.

4 patents in portfolio

US12590148utility2026
Methods for the Simultaneous Expansion of Multiple Immune Cell Types, Related Compositions and Uses of Same in Cancer Immunotherapy
0 cites
US12398187utility2025
Cd19-directed Chimeric Antigen Receptors and Uses Thereof in Immunotherapy
0 cites
US12351617utility2025
Immune Cells Comprising Truncated NKG2D Chimeric Receptors
0 cites
US12012458utility2024
Genetically Modified Natural Killer Cells for Cd70-directed Cancer Immunotherapy
0 cites